Keyphrases
Ewing Sarcoma
74%
Tumor
56%
Targeted Locus Amplification
53%
Pediatric Tumors
53%
Patient-specific
53%
Functional Impairment
53%
Liquid Biopsy
53%
Antigen-presenting Cells
53%
Single-cell Transcriptome Analysis
53%
Cancer Research
53%
Desmoplastic Small Round Cell Tumor (DSRCT)
53%
In Cancer
53%
Xenograft Model
53%
Therapeutic Potential
53%
EWSR1-WT1
53%
In Vitro Model
53%
Organoid Models
53%
Tumor Organoids
46%
Cell-free DNA (cfDNA)
42%
Tumor Xenograft
35%
Fusion Gene
32%
Specific Marker
32%
Region of Interest
21%
Rhabdomyosarcoma
21%
Droplet Digital PCR (ddPCR)
21%
Tumor-specific
21%
Neuroblastoma
21%
Plasma Samples
21%
MerTK
20%
Immune Microenvironment
19%
Tumor Cells
18%
Phenotypic Heterogeneity
17%
High Efficiency
17%
Patient-derived Xenograft
17%
Tumorigenesis
17%
Xenograft
17%
Patient Materials
17%
Recent Advances
17%
Organoids
17%
Genetic Heterogeneity
17%
Therapeutic Target
13%
Preclinical in Vitro Models
13%
Molecular Mechanism
13%
WT1 Expression
13%
Recurrent Point
10%
Specific Primers
10%
Diagnostic pipeline
10%
Pediatric Malignancy
10%
Minimally Invasive
10%
Neuroblastoma Tumor
10%
Medicine and Dentistry
Neoplasm
100%
Ewing Sarcoma
71%
Organoid
62%
Cancer Research
60%
Solid Malignant Neoplasm
53%
Antigen Presenting Cell
53%
Liquid Biopsy
53%
Gene Expression Profiling
53%
Pediatrics
53%
Desmoplastic Small Round Cell Tumor
53%
Xenograft
53%
In Vitro
53%
Cell-Free DNA
35%
Fusion Gene
26%
Ganglioneuroblastoma
26%
Tumor Xenograft
26%
Specific Tumor
17%
Rhabdomyosarcoma
17%
Diagnosis
17%
Droplet Digital Polymerase Chain Reaction
17%
Immunity
17%
Tumor Cell
17%
Carcinogenesis
13%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Point Mutation
8%
Sensitive Detection
8%
Childhood Cancer
8%
Prevalence
8%
Minimal Residual Disease
8%
SNP Array
8%
Immunosuppressive Drug
7%
T Cell
7%
RNA Sequence
7%
Immunocompetent Cell
7%
Immunotherapy
7%
Chromosome Translocation
6%
Gene Fusion
6%
Cell Survival
6%
Cell Shape
6%
Soft Tissue Sarcoma
6%
Cancer
6%
Drug Screening
6%
